|
Stemtech Corporation (STEK) |
|
Stemtech Corporation
STEK's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Stemtech growth rates, revenue grew
by 17.52 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2441
Pharmacy Services & Retail Drugstore industry recorded
growth of revenues by 7.11 %
Stemtech net loss increased from $0 millions, to $-1 millions in II. Quarter 2024,
• More on STEK's Growth
|
|
Stemtech realized a net loss in trailing twelve months.
Stemtech realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
22.75 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.77.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.22.
• More on STEK's Valuation
|
|
|
|
|
Stemtech realized net loss in trailing twelve months.
Stemtech realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
22.75 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.77.
Pharmacy Services & Retail Drugstore industry's Price to Sales ratio is at 0.22.
• More on STEK's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com